Safety of convalescent plasma to treat COVID-19: Systematic review
<p>Background: Currently, Coronavirus disease (COVID-19) was reported in more than 204 countries. As of April 10, 2020, a total of 1,605,729 confirmed cases and 95,766 deaths had been reported worldwide. There are no approved specific antiviral agents targeting the novel virus. Convalescent pl...
Saved in:
Main Authors: | Ephrem Awulachew (Author), Kuma Diriba (Author), Asrat Anja (Author), Firehiwot Belayneh (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2020-06-29.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Cryptosporidium species among HIV/AIDS patients in Sub Saharan Africa; Systematic Review and Meta-Analysis
by: Ephrem Awulachew, et al.
Published: (2020) -
Convalescent Plasma in the Treatment of Severe COVID-19: A Systematic Review and Meta-Analysis
by: Xuanguo ZHANG, et al.
Published: (2020) -
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
by: Peng, Henry T, et al.
Published: (2021) -
Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022) -
Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
by: Henry T Peng, et al.
Published: (2021)